{"url_path":"/sec/otlc/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-023181-index.html","accession_number":"0001493152-26-023181","cik":"0000908259","ticker":"OTLC","issuer_name":"Oncotelic Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-023181-index.html","primary_entity_key":"0000908259","primary_entity_name":"Oncotelic Therapeutics, Inc."},"word_count":98,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors**\n\n \n\nFor\ninformation about the risks and uncertainties related to our business, please see the risk factors described in our 2025 Annual Report\non Form 10-K for the year ended December 31, 2025 filed with the SEC on April 15, 2026 and other SEC filings. The risks described below\nand in our 2025 Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently\nknown to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or\noperating results."}